Terms: = Sarcomas AND WHSC1, 7468, O96028, WHS, TRX5, REIIBP, NSD2, MMSET, MGC176638, KIAA1090, FLJ23286
6 results:
1. Targeting the Nuclear Receptor-Binding SET Domain Family of Histone Lysine Methyltransferases for Cancer Therapy: Recent Progress and Perspectives.
Shrestha A; Kim N; Lee SJ; Jeon YH; Song JJ; An H; Cho SJ; Kadayat TM; Chin J
J Med Chem; 2021 Oct; 64(20):14913-14929. PubMed ID: 34488340
[TBL] [Abstract] [Full Text] [Related]
2. Transdifferentiation of mantle cell lymphoma into sarcoma with limited neuromuscular differentiation after conventional chemotherapy.
Kawashima I; Oishi N; Kasai K; Inoue T; Hosokawa E; Nakadate A; Matsuura M; Kumagai T; Koshiishi M; Yamamoto T; Nakajima K; Tanaka M; Kondo T; Kirito K
Virchows Arch; 2022 May; 480(5):1101-1105. PubMed ID: 34226971
[TBL] [Abstract] [Full Text] [Related]
3. Epigenomic Reordering Induced by Polycomb Loss Drives Oncogenesis but Leads to Therapeutic Vulnerabilities in Malignant Peripheral Nerve Sheath Tumors.
Wojcik JB; Marchione DM; Sidoli S; Djedid A; Lisby A; Majewski J; Garcia BA
Cancer Res; 2019 Jul; 79(13):3205-3219. PubMed ID: 30898839
[TBL] [Abstract] [Full Text] [Related]
4. Histone methyltransferase nsd2 regulates apoptosis and chemosensitivity in osteosarcoma.
He C; Liu C; Wang L; Sun Y; Jiang Y; Hao Y
Cell Death Dis; 2019 Jan; 10(2):65. PubMed ID: 30683853
[TBL] [Abstract] [Full Text] [Related]
5. Characterization of H3.3K36M as a tool to study H3K36 methylation in cancer cells.
Sankaran SM; Gozani O
Epigenetics; 2017; 12(11):917-922. PubMed ID: 28933651
[TBL] [Abstract] [Full Text] [Related]
6. nsd2 promotes osteosarcoma cell proliferation and metastasis by inhibiting E-cadherin expression.
Lu MH; Fan MF; Yu XD
Eur Rev Med Pharmacol Sci; 2017 Mar; 21(5):928-936. PubMed ID: 28338204
[TBL] [Abstract] [Full Text] [Related]